Insulin is an important neuroprotective growth factor and neuronal insulin resistance may underlie the link between the presence of metabolic abnormalities and both Alzheimer’s disease and Parkinson’s disease [148, 149]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.